Expression biomarkers for clinical efficacy and outcome prediction in cancer

Author： Strand Kathryn J   Khalak Hanif   Strovel Jeffrey W   Ebner Reinhard   Augustus Meena  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.1, 2006-01, pp. : 105-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Proteomic Prediction of Disease Outcome in Cancer: Clinical Framework and Current Status

By Steinert R.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 2, 2003-01 ,pp. : 107-115

Adis International

Access to resources Recommend Favorite

Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome

By  

Current Pharmacogenomics, Vol. 1, Iss. 3, 2003-09 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4879-4898

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1225-1230

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer

By Mahler C.   Verhelst J.   Denis L.  

Clinical Pharmacokinetics, Vol. 34, Iss. 5, 1998-05 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite